BREAST CANCER
![Foto de BREAST CANCER](/img/grupo.png)
![Foto de Gustave Roussy Cancer Campus](/img/noimage_org.png)
Gustave Roussy Cancer Campus
Villejuif, FranciaPublications in collaboration with researchers from Gustave Roussy Cancer Campus (2)
2023
-
Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 30, pp. 4768-4778
2018
-
Phase II study of buparlisib (BKM120) and trastuzumab in patients with HER2+ locally advanced or metastatic breast cancer resistant to trastuzumab-based therapy
Breast Cancer Research and Treatment, Vol. 168, Núm. 2, pp. 357-364